乳腺癌放疗后甲状腺功能减退的正常组织并发症概率模型
研究纳入2009至2016年接受全乳照射的1063例乳腺癌患者,构建LKB和多变量NTCP模型预测放疗诱导甲状腺功能减退(RIHT)。中位随访77.7个月,4%患者发生RIHT,多变量模型预测性能优于LKB模型(AUC 0.62 vs 0.54),全身治疗、年龄和甲状腺V10是显著预后因素。
要点
- 多变量NTCP模型预测RIHT的AUC为0.62,优于LKB模型的0.54。
- 全身治疗、年龄和甲状腺V10是RIHT的显著预后因素。
- 同时超过全身治疗、年龄≥40岁和甲状腺V10≥26%三个界值的患者RIHT累积发生率显著更高(P<0.005)。
核心结论
- 全身治疗、年龄和甲状腺V10被确定为发生RIHT的强危险因素。
- 本研究的NTCP模型通过识别高危患者,为临床医生预测和预防甲状腺功能减退提供了有价值的见解。
研究设计与样本
- 回顾性分析2009至2016年间接受全乳照射的1063例乳腺癌患者。
- 利用个体剂量体积直方图构建LKB模型和多变量逻辑回归NTCP模型。
- 采用自举法进行内部验证,并使用AUC和Hosmer-Lemeshow拟合优度检验评估模型性能。
主要发现
- 中位随访77.7个月,4%的患者发生RIHT。
- LKB和多变量NTCP模型的预测结果与观察结果均显示显著一致性(HL P值>0.05)。
- 多变量NTCP模型预测RIHT的AUC为0.62,优于LKB模型的AUC 0.54。
- 在多变量模型中,全身治疗、年龄和接受≥10 Gy的甲状腺体积百分比(V10)是RIHT的显著预后因素。
- 同时超过全身治疗、年龄≥40岁和甲状腺V10≥26%三个危险预测因素界值的患者,RIHT累积发生率显著更高(P<0.005)。
关键数值与推荐
- 多变量NTCP模型预测RIHT的AUC为0.62,LKB模型为0.54。
- 全身治疗、年龄≥40岁和甲状腺V10≥26%三个危险预测因素均超过界值的患者RIHT累积发生率显著更高(P<0.005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to develop Lyman-Kutcher-Burman (LKB) and multivariable normal tissue complication probability (NTCP) models to predict the risk of radiation-induced hypothyroidism (RIHT) in breast cancer patients. MATERIALS AND METHODS: A total of 1,063 breast cancer patients who underwent whole breast irradiation between 2009 and 2016 were analyzed. Individual dose-volume histograms were used to generate LKB and multivariable logistic regression models. LKB model was fit using the thyroid radiation dose-volume parameters. A multivariable model was constructed to identify potential dosimetric and clinical parameters associated with RIHT. Internal validation was conducted using bootstrapping techniques, and model performance was evaluated using the area under the curve (AUC) and Hosmer-Lemeshow (HL) goodness-of-fit test. RESULTS: RIHT developed in 4 % of patients with a median follow-up of 77.7 months. LKB and multivariable NTCP models exhibited significant agreement between the predicted and observed results (HL P values > 0.05). The multivariable NTCP model outperformed the LKB model in predicting RIHT (AUC 0.62 vs. 0.54). In the multivariable model, systemic therapy, age, and percentage of thyroid volume receiving ≥ 10 Gy (V10) were significant prognostic factors for RIHT. The cumulative incidence of RIHT was significantly higher in patients who exceeded the cut-off values for all three risk predictors (systemic therapy, age ≥ 40 years, and thyroid V10 ≥ 26 %, P < 0.005). CONCLUSIONS: Systemic therapy, age, and V10 of the thyroid were identified as strong risk factors for the development of RIHT. Our NTCP models provide valuable insights to clinicians for predicting and preventing hypothyroidism by identifying high-risk patients.
引用
- Park YI, Cho MS, Chang JS, et al. Normal tissue complication probability models of hypothyroidism after radiotherapy for breast cancer. Clin Transl Radiat Oncol. 2024. PMID: 38317677. doi:10.1016/j.ctro.2024.100734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。